Skip to main content
Erschienen in: Indian Journal of Pediatrics 11/2019

13.07.2019 | Original Article

Is Expanded Newborn Screening Adequate to Detect Indian Biochemical Low Excretor Phenotype Patients of Glutaric Aciduria Type I?

verfasst von: Muntaj Shaik, Kruthika-Vinod T. P., Mahesh Kamate, Vedamurthy A. B.

Erschienen in: Indian Journal of Pediatrics | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate if expanded newborn screening using tandem mass spectroscopy (TMS) is adequate to detect low excretor phenotype in Indian Glutaric aciduria type I (GA-I) patients.

Methods

Ten GA-I patients were investigated for blood glutaryl carnitine (C5DC) levels on dried blood spot (DBS) by tandem mass spectroscopy and urine glutaric acid (GA) and 3-hydroxyglutaric acid (3-OH-GA) by gas chromatography-mass spectroscopy. The student’s T test and Pearson’s correlation were applied to draw a relationship between various biochemical parameters. Further confirmation of low excretors by DNA mutation analysis in the glutaryl CoA dehydrogenase (GCDH) gene was performed by polymerase chain reaction and Sangers sequencing.

Results

Among 10 GA-I patients, 7 patients were found to have high excretor, and 3 were found to have low excretor phenotype. The low excretors were found to have GCDH gene mutations. The mean C5DC levels in high and low excretors were 2.61 ± 2.02 μmol/L and 2.31 ± 1.00 μmol/L, respectively. In high excretors, C5DC levels correlated with GA (r = 0.95). In low excretors, C5DC levels correlated with 3-OH-GA (r = 0.99). No significant difference was found between C5DC levels of high and low excretors (p = 0.82).

Conclusions

The MS/MS, C5DC screening is a sensitive technique and detected 10 GA-I patients. Irrespective of the urine organic acid levels, Indian GA-I patients including low excretors seem to have a significantly elevated C5DC level and well above the stipulated cut-off values and therefore, expanded newborn screening is probably adequate to diagnose them.
Literatur
1.
Zurück zum Zitat Barić I, Baraka K, Maradin M, et al. Glutaric aciduria type 1: an example of the importance of early detection of so-called cerebral organic aciduria. [Article in Croatian]. Lijec Vjesn. 2003;125:312–6.PubMed Barić I, Baraka K, Maradin M, et al. Glutaric aciduria type 1: an example of the importance of early detection of so-called cerebral organic aciduria. [Article in Croatian]. Lijec Vjesn. 2003;125:312–6.PubMed
2.
Zurück zum Zitat Strauss KA, Puffenberger EG, Robinson DL, Morton DH. Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet. 2003;121C:38–52.CrossRef Strauss KA, Puffenberger EG, Robinson DL, Morton DH. Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet. 2003;121C:38–52.CrossRef
3.
Zurück zum Zitat Kölker S, Garbade SF, Greenberg CR, et al. Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res. 2006;59:840–7.CrossRef Kölker S, Garbade SF, Greenberg CR, et al. Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res. 2006;59:840–7.CrossRef
4.
Zurück zum Zitat Vaidyanathan K, Narayanan MP, Vasudevan DM. Organic acidurias: an updated review. Indian J Clin Biochem. 2011;26:319–25.CrossRef Vaidyanathan K, Narayanan MP, Vasudevan DM. Organic acidurias: an updated review. Indian J Clin Biochem. 2011;26:319–25.CrossRef
5.
Zurück zum Zitat Babu RP, Bishnupriya G, Thushara PK, et al. Detection of glutaric acidemia type 1 in infants through tandem mass spectrometry. Mol Genet Metabol Rep. 2015;3:75–9.CrossRef Babu RP, Bishnupriya G, Thushara PK, et al. Detection of glutaric acidemia type 1 in infants through tandem mass spectrometry. Mol Genet Metabol Rep. 2015;3:75–9.CrossRef
6.
Zurück zum Zitat Fraidakis MJ, Liadinioti C, Stefanis L, et al. Rare late-onset presentation of glutaric aciduria type I in a 16-year-old woman with a novel GCDH mutation. JIMD Rep. 2015;18:85–92.CrossRef Fraidakis MJ, Liadinioti C, Stefanis L, et al. Rare late-onset presentation of glutaric aciduria type I in a 16-year-old woman with a novel GCDH mutation. JIMD Rep. 2015;18:85–92.CrossRef
7.
Zurück zum Zitat Busquets C, Merinero B, Christensen E, et al. Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res. 2000;48:315–22.CrossRef Busquets C, Merinero B, Christensen E, et al. Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res. 2000;48:315–22.CrossRef
8.
Zurück zum Zitat Boy N, Mengler K, Thimm E, et al. Newborn screening: a disease-changing intervention for glutaric aciduria type 1. Ann Neurol. 2018;83:970–9.CrossRef Boy N, Mengler K, Thimm E, et al. Newborn screening: a disease-changing intervention for glutaric aciduria type 1. Ann Neurol. 2018;83:970–9.CrossRef
9.
Zurück zum Zitat Hedlund GL, Longo N, Pasquali M. Glutaric acidemia type 1. Am J Med Genet P C Semin Med Genet. 2006;142C:86–94.CrossRef Hedlund GL, Longo N, Pasquali M. Glutaric acidemia type 1. Am J Med Genet P C Semin Med Genet. 2006;142C:86–94.CrossRef
10.
Zurück zum Zitat Kolker S, Christensen E, Leonard JV, et al. Diagnosis and management of glutaric aciduria type I-revised recommendations. J Inherit Metab Dis. 2011;34:677–94.CrossRef Kolker S, Christensen E, Leonard JV, et al. Diagnosis and management of glutaric aciduria type I-revised recommendations. J Inherit Metab Dis. 2011;34:677–94.CrossRef
11.
Zurück zum Zitat Boy N, Mühlhausen C, Maier EM, et al. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis. 2017;40:75–101.CrossRef Boy N, Mühlhausen C, Maier EM, et al. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis. 2017;40:75–101.CrossRef
12.
Zurück zum Zitat Heringer J, Boy N, Burgard P, Okun JG, Kolker S. Newborn screening for glutaric aciduria type I: benefits and limitations. Int J Neonatal Screen. 2015;1:57–68.CrossRef Heringer J, Boy N, Burgard P, Okun JG, Kolker S. Newborn screening for glutaric aciduria type I: benefits and limitations. Int J Neonatal Screen. 2015;1:57–68.CrossRef
13.
Zurück zum Zitat Horster F, Kolker S, Loeber JG, Cornel MC, Hoffmann GF, Burgard GF. Newborn screening programmes in europe, arguments and efforts regarding harmonisation: focus on organic acidurias. JIMD Rep. 2017;32:105–15.CrossRef Horster F, Kolker S, Loeber JG, Cornel MC, Hoffmann GF, Burgard GF. Newborn screening programmes in europe, arguments and efforts regarding harmonisation: focus on organic acidurias. JIMD Rep. 2017;32:105–15.CrossRef
14.
Zurück zum Zitat Chace DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem. 2003;49:1797–817.CrossRef Chace DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem. 2003;49:1797–817.CrossRef
15.
Zurück zum Zitat Heringer J, Boy SP, Ensenauer R, et al. Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol. 2010;68:743–52.CrossRef Heringer J, Boy SP, Ensenauer R, et al. Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol. 2010;68:743–52.CrossRef
16.
Zurück zum Zitat Wilcken B, Wiley V, Hammond J. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med. 2003;348:2304–12.CrossRef Wilcken B, Wiley V, Hammond J. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med. 2003;348:2304–12.CrossRef
17.
Zurück zum Zitat Lindner M, Kölker S, Schulze A, Christensen E, Greenberg CR, Hoffmann GF. Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2004;27:851–9.CrossRef Lindner M, Kölker S, Schulze A, Christensen E, Greenberg CR, Hoffmann GF. Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2004;27:851–9.CrossRef
18.
Zurück zum Zitat Smith WE, Millington DS, Koeberl DK, Lesser PS. Glutaric acidemia, type I, missed by newborn screening in an infant with dystonia following promethazine administration. Pediatrics. 2001;107:1184–7.CrossRef Smith WE, Millington DS, Koeberl DK, Lesser PS. Glutaric acidemia, type I, missed by newborn screening in an infant with dystonia following promethazine administration. Pediatrics. 2001;107:1184–7.CrossRef
19.
Zurück zum Zitat Kaur G, Thakur K, Kataria S, et al. Current and future perspective of newborn screening: an Indian scenario. J Pediatr Endocrinol Metab. 2016;29:5–13.CrossRef Kaur G, Thakur K, Kataria S, et al. Current and future perspective of newborn screening: an Indian scenario. J Pediatr Endocrinol Metab. 2016;29:5–13.CrossRef
20.
Zurück zum Zitat Devi ARR, Naushad SM. Newborn screening in India. Indian J Pediatr. 2004;71:157–60.CrossRef Devi ARR, Naushad SM. Newborn screening in India. Indian J Pediatr. 2004;71:157–60.CrossRef
21.
Zurück zum Zitat Banta-Wright SA, Steiner RD. Tandem mass spectrometry in newborn screening: a primer for neonatal and perinatal nurses. J Perinat Neonatal Nurs. 2004;18:41–58.CrossRef Banta-Wright SA, Steiner RD. Tandem mass spectrometry in newborn screening: a primer for neonatal and perinatal nurses. J Perinat Neonatal Nurs. 2004;18:41–58.CrossRef
22.
Zurück zum Zitat Rakheja D, Jones VK, Burlina AB, Bennett MJ. Diagnosis of glutaric acidemia type I: a cautionary note. Lab Med. 2005;36:174–7.CrossRef Rakheja D, Jones VK, Burlina AB, Bennett MJ. Diagnosis of glutaric acidemia type I: a cautionary note. Lab Med. 2005;36:174–7.CrossRef
23.
Zurück zum Zitat Couce ML, López-Suárez O, Bóveda MD, et al. Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis. Eur J Paediatr Neurol. 2013;17:383–9.CrossRef Couce ML, López-Suárez O, Bóveda MD, et al. Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis. Eur J Paediatr Neurol. 2013;17:383–9.CrossRef
24.
Zurück zum Zitat Radha Rama Devi A, Ramesh VA, Nagarajaram HA, Satish SP, Jayanthi U, Lingappa L. Spectrum of mutations in Glutaryl-CoA dehydrogenase gene in glutaric aciduria type I--study from South India. Brain Dev. 2016;38:54–60.CrossRef Radha Rama Devi A, Ramesh VA, Nagarajaram HA, Satish SP, Jayanthi U, Lingappa L. Spectrum of mutations in Glutaryl-CoA dehydrogenase gene in glutaric aciduria type I--study from South India. Brain Dev. 2016;38:54–60.CrossRef
25.
Zurück zum Zitat Gupta N, Singh PK, Kumar M, et al. Glutaric acidemia type 1-clinico-molecular profile and novel mutations in GCDH gene in Indian patients. JIMD Rep. 2015;21:45–55.CrossRef Gupta N, Singh PK, Kumar M, et al. Glutaric acidemia type 1-clinico-molecular profile and novel mutations in GCDH gene in Indian patients. JIMD Rep. 2015;21:45–55.CrossRef
26.
Zurück zum Zitat Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q. Role of carnitine in disease. Nutr Metab. 2010;7:30.CrossRef Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q. Role of carnitine in disease. Nutr Metab. 2010;7:30.CrossRef
27.
Zurück zum Zitat Tortorelli S, Hahn SH, Cowan TM, Brewster TG, Rinaldo P, Matern D. The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric aciduria type I. Mol Genet Metab. 2005;84:137–43.CrossRef Tortorelli S, Hahn SH, Cowan TM, Brewster TG, Rinaldo P, Matern D. The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric aciduria type I. Mol Genet Metab. 2005;84:137–43.CrossRef
28.
Zurück zum Zitat Keyser B, Glatzel M, Stellmer F, et al. Transport and distribution of 3-hydroxyglutaric acid before and during induced encephalopathic crises in a mouse model of glutaric aciduria type 1. Biochim Biophys Acta Mol Basis Dis. 2008;1782:385–90.CrossRef Keyser B, Glatzel M, Stellmer F, et al. Transport and distribution of 3-hydroxyglutaric acid before and during induced encephalopathic crises in a mouse model of glutaric aciduria type 1. Biochim Biophys Acta Mol Basis Dis. 2008;1782:385–90.CrossRef
29.
Zurück zum Zitat Al-Dirbashi OY, Kölker S, Ng D, et al. Diagnosis of glutaric aciduria type 1 by measuring 3-hydroxyglutaric acid in dried urine spots by liquid chromatography tandem mass spectrometry. J Inherit Metab Dis. 2011;34:173–80.CrossRef Al-Dirbashi OY, Kölker S, Ng D, et al. Diagnosis of glutaric aciduria type 1 by measuring 3-hydroxyglutaric acid in dried urine spots by liquid chromatography tandem mass spectrometry. J Inherit Metab Dis. 2011;34:173–80.CrossRef
Metadaten
Titel
Is Expanded Newborn Screening Adequate to Detect Indian Biochemical Low Excretor Phenotype Patients of Glutaric Aciduria Type I?
verfasst von
Muntaj Shaik
Kruthika-Vinod T. P.
Mahesh Kamate
Vedamurthy A. B.
Publikationsdatum
13.07.2019
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 11/2019
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-019-03017-z

Weitere Artikel der Ausgabe 11/2019

Indian Journal of Pediatrics 11/2019 Zur Ausgabe

Häufigste Gründe für Brustschmerzen bei Kindern

06.05.2024 Pädiatrische Diagnostik Nachrichten

Akute Brustschmerzen sind ein Alarmsymptom par exellence, schließlich sind manche Auslöser lebensbedrohlich. Auch Kinder klagen oft über Schmerzen in der Brust. Ein Studienteam ist den Ursachen nachgegangen.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Durch übermäßige Internetnutzung wird oft die Schule verpasst

Häufige Fehlzeiten in der Schule können durch physische und psychische Probleme verursacht werden. Wie in einer Studie aus Finnland nun belegt wird, führt auch die exzessive Nutzung des Internets gehäuft zu Abwesenheiten.

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.